We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Omnicell (OMCL) Up 0.4% Since Last Earnings Report: Can It Continue?
Read MoreHide Full Article
A month has gone by since the last earnings report for Omnicell (OMCL - Free Report) . Shares have added about 0.4% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Omnicell due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.
Omnicell Beats on Earnings in Q2
Omnicell, Inc.’s OMCL second-quarter 2019 adjusted earnings per share (EPS) of 67 cents outpaced the Zacks Consensus Estimate by 4.7%.
Also, adjusted EPS surged 45.6% from the year-ago figure and surpassed the company’s guided range of 61-66 cents as well.
Revenues in Detail
Adjusted revenues in the second quarter increased 15.2% year over year to $217.4 million. The top line also trumped the Zacks Consensus Estimate of $213 million.
Quarterly Details
On a segmental basis, Product revenues improved 17.7% year over year to $158.4 million in the reported quarter.
Moreover, Service and other revenues climbed 9.2% year over year to $59 million.
Operational Update
In the quarter under review, Omnicell's adjusted gross profit rose 17.2% to $104 million. Adjusted gross margin expanded 80 basis points (bps) to 47.9%.
Adjusted operating profit totaled $18.8 million, reflecting a 155.8% jump from the prior-year quarter. Adjusted operating margin in the second quarter grew 474 bps to 13%.
SG&A expenses inched up 3.8% year over year to $68.4 million. Moreover, research and development expenses escalated 8.6% year over year to $16.8 million. Also, adjusted operating expenses were $85.2 million in the second quarter, up 4.7% year over year.
Financial Update
Omnicell exited the second quarter with cash and cash equivalents of $87.5 million compared with $77.2 million at the end of the first quarter.
Guidance
For the third quarter of 2019, Omnicell expects adjusted revenues between $227 million and $233 million. The Zacks Consensus Estimate for the metric stands at $231.9 million, within the guided range.
On an adjusted basis, product revenues are expected between $168 million and $173 million while service revenues are projected within $59-$60 million.
Third-quarter adjusted EPS is envisioned in the band of 67-72 cents. The Zacks Consensus Estimate for the same is pegged at 71 cents, close to the upper end of the predicted range.
For 2019, adjusted revenues are now anticipated within $886-$900 million, narrowed from the earlier band of $880-$900 million. The Zacks Consensus Estimate for the same is pinned on $891.9 million, within the guided range.
Product revenues for the full year are estimated within $653-$663 million while service revenues are expected between $233 million and $237 million.
Adjusted EPS is forecast between $2.65 and $2.82 for 2019 (earlier range was $2.62-$2.82). The Zacks Consensus Estimate for the metric stands at $2.77, within the guided range.
How Have Estimates Been Moving Since Then?
Estimates revision followed a flat path over the past two months.
VGM Scores
At this time, Omnicell has a strong Growth Score of A, though it is lagging a bit on the Momentum Score front with a B. Charting a somewhat similar path, the stock was allocated a grade of C on the value side, putting it in the middle 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Omnicell has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.
See More Zacks Research for These Tickers
Normally $25 each - click below to receive one report FREE:
Image: Bigstock
Omnicell (OMCL) Up 0.4% Since Last Earnings Report: Can It Continue?
A month has gone by since the last earnings report for Omnicell (OMCL - Free Report) . Shares have added about 0.4% in that time frame, outperforming the S&P 500.
Will the recent positive trend continue leading up to its next earnings release, or is Omnicell due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers.
Omnicell Beats on Earnings in Q2
Omnicell, Inc.’s OMCL second-quarter 2019 adjusted earnings per share (EPS) of 67 cents outpaced the Zacks Consensus Estimate by 4.7%.
Also, adjusted EPS surged 45.6% from the year-ago figure and surpassed the company’s guided range of 61-66 cents as well.
Revenues in Detail
Adjusted revenues in the second quarter increased 15.2% year over year to $217.4 million. The top line also trumped the Zacks Consensus Estimate of $213 million.
Quarterly Details
On a segmental basis, Product revenues improved 17.7% year over year to $158.4 million in the reported quarter.
Moreover, Service and other revenues climbed 9.2% year over year to $59 million.
Operational Update
In the quarter under review, Omnicell's adjusted gross profit rose 17.2% to $104 million. Adjusted gross margin expanded 80 basis points (bps) to 47.9%.
Adjusted operating profit totaled $18.8 million, reflecting a 155.8% jump from the prior-year quarter. Adjusted operating margin in the second quarter grew 474 bps to 13%.
SG&A expenses inched up 3.8% year over year to $68.4 million. Moreover, research and development expenses escalated 8.6% year over year to $16.8 million. Also, adjusted operating expenses were $85.2 million in the second quarter, up 4.7% year over year.
Financial Update
Omnicell exited the second quarter with cash and cash equivalents of $87.5 million compared with $77.2 million at the end of the first quarter.
Guidance
For the third quarter of 2019, Omnicell expects adjusted revenues between $227 million and $233 million. The Zacks Consensus Estimate for the metric stands at $231.9 million, within the guided range.
On an adjusted basis, product revenues are expected between $168 million and $173 million while service revenues are projected within $59-$60 million.
Third-quarter adjusted EPS is envisioned in the band of 67-72 cents. The Zacks Consensus Estimate for the same is pegged at 71 cents, close to the upper end of the predicted range.
For 2019, adjusted revenues are now anticipated within $886-$900 million, narrowed from the earlier band of $880-$900 million. The Zacks Consensus Estimate for the same is pinned on $891.9 million, within the guided range.
Product revenues for the full year are estimated within $653-$663 million while service revenues are expected between $233 million and $237 million.
Adjusted EPS is forecast between $2.65 and $2.82 for 2019 (earlier range was $2.62-$2.82). The Zacks Consensus Estimate for the metric stands at $2.77, within the guided range.
How Have Estimates Been Moving Since Then?
Estimates revision followed a flat path over the past two months.
VGM Scores
At this time, Omnicell has a strong Growth Score of A, though it is lagging a bit on the Momentum Score front with a B. Charting a somewhat similar path, the stock was allocated a grade of C on the value side, putting it in the middle 20% for this investment strategy.
Overall, the stock has an aggregate VGM Score of B. If you aren't focused on one strategy, this score is the one you should be interested in.
Outlook
Omnicell has a Zacks Rank #3 (Hold). We expect an in-line return from the stock in the next few months.